tiprankstipranks
Trending News
More News >
Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)
:INDRAMEDCO
India Market
Advertisement

Indraprastha Medical Corporation Limited (INDRAMEDCO) Financial Statements

Compare
0 Followers

Indraprastha Medical Corporation Limited Financial Overview

Indraprastha Medical Corporation Limited's market cap is currently ₹44.64B. The company's EPS TTM is ₹4.47; its P/E ratio is 27.73; and it has a dividend yield of 0.93%. Indraprastha Medical Corporation Limited is scheduled to report earnings on May 16, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 13.56B₹ 12.45B₹ 10.99B₹ 8.62B₹ 5.96B
Gross Profit₹ 4.94B₹ 4.54B₹ 6.25B₹ 4.79B₹ 3.47B
Operating Income₹ 4.94B₹ 1.56B₹ 1.12B₹ 851.30M₹ 76.60M
EBITDA₹ 2.44B₹ 2.07B₹ 1.61B₹ 1.17B₹ 409.48M
Net Income₹ 1.61B₹ 1.24B₹ 861.50M₹ 586.20M₹ 23.30M
Balance Sheet
Cash & Short-Term Investments₹ 3.22B₹ 2.28B₹ 1.36B₹ 707.90M₹ 296.10M
Total Assets₹ 8.52B₹ 7.23B₹ 5.55B₹ 4.62B₹ 4.32B
Total Debt₹ 327.60M₹ 339.50M₹ 24.80M₹ 53.10M₹ 78.18M
Net Debt₹ -2.89B₹ -276.50M₹ -497.80M₹ -364.30M₹ -171.03M
Total Liabilities₹ 2.55B₹ 2.45B₹ 1.76B₹ 1.36B₹ 1.59B
Stockholders' Equity₹ 5.97B₹ 4.78B₹ 3.79B₹ 3.25B₹ 2.73B
Cash Flow
Free Cash Flow₹ 1.20B₹ 1.31B₹ 998.90M₹ 418.10M₹ 69.35M
Operating Cash Flow₹ 1.57B₹ 2.00B₹ 1.44B₹ 712.90M₹ 278.98M
Investing Cash Flow₹ -1.11B₹ -1.58B₹ -1.08B₹ -511.00M₹ -201.62M
Financing Cash Flow₹ -458.80M₹ -323.80M₹ -260.40M₹ -33.70M₹ -31.47M
Currency in INR

Indraprastha Medical Corporation Limited Earnings and Revenue History

Indraprastha Medical Corporation Limited Debt to Assets

Indraprastha Medical Corporation Limited Cash Flow

Indraprastha Medical Corporation Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis